Keywords: Eli Lilly, Second-quarter 2011 financial results

Eli Lilly sees downturn in 2nd-qtr quarter EPS, but sales rise 9%

Article | 22 July 2011

Print This

There were mixed second-quarter 2011 financial results from US drug major Eli Lilly (NYSE: LLY), which posted 9% growth in sales to $6.25 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in